A subset of HLA-DP molecules serve as ligands for the natural cytotoxicity receptor NKp44

[1]  J. Rossjohn,et al.  Structural Basis for CD96 Immune Receptor Recognition of Nectin-like Protein-5, CD155. , 2019, Structure.

[2]  D. Fremont,et al.  Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor , 2017, Cell.

[3]  M. Purbhoo,et al.  KIR2DS2 recognizes conserved peptides derived from viral helicases in the context of HLA-C , 2017, Science Immunology.

[4]  M. Altfeld,et al.  Peptide-specific engagement of the activating NK cell receptor KIR2DS1 , 2017, Scientific Reports.

[5]  M. Altfeld,et al.  Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1 , 2016, Nature Immunology.

[6]  H. Hocine,et al.  Natural cytotoxicity receptor splice variants orchestrate the distinct functions of human natural killer cell subtypes , 2015, Nature Communications.

[7]  Jaclyn K. Mann,et al.  Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South Africa , 2015, PLoS medicine.

[8]  Effie W Petersdorf,et al.  High HLA-DP Expression and Graft-versus-Host Disease. , 2015, The New England journal of medicine.

[9]  Olli Simell,et al.  HLA-DPB1*04:01 Protects Genetically Susceptible Children from Celiac Disease Autoimmunity in the TEDDY Study , 2015, The American Journal of Gastroenterology.

[10]  James McCluskey,et al.  T cell antigen receptor recognition of antigen-presenting molecules. , 2015, Annual review of immunology.

[11]  J. Rossjohn,et al.  Peptide-Dependent Recognition of HLA-B*57:01 by KIR3DS1 , 2015, Journal of Virology.

[12]  Hailiang Huang,et al.  High density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis , 2014, Nature Genetics.

[13]  Mark M. Davis,et al.  Deconstructing the Peptide-MHC Specificity of T Cell Recognition , 2014, Cell.

[14]  M. Mearin,et al.  T-cell receptor recognition of HLA-DQ2–gliadin complexes associated with celiac disease , 2014, Nature Structural &Molecular Biology.

[15]  J. Rossjohn,et al.  Mutational and Structural Analysis of KIR3DL1 Reveals a Lineage-Defining Allotypic Dimorphism That Impacts Both HLA and Peptide Sensitivity , 2014, The Journal of Immunology.

[16]  P. Debré,et al.  Identification of a cellular ligand for the natural cytotoxicity receptor NKp44. , 2013, Blood.

[17]  J. Falkenburg,et al.  HLA class II upregulation during viral infection leads to HLA-DP-directed graft-versus-host disease after CD4+ donor lymphocyte infusion. , 2013, Blood.

[18]  M. Lenarz,et al.  RORγt⁺ innate lymphoid cells acquire a proinflammatory program upon engagement of the activating receptor NKp44. , 2013, Immunity.

[19]  T. Beddoe,et al.  Targeting of a natural killer cell receptor family by a viral immunoevasin , 2013, Nature Immunology.

[20]  M. Altfeld,et al.  Control of human viral infections by natural killer cells. , 2013, Annual review of immunology.

[21]  Richard Apps,et al.  A Novel Variant Marking HLA-DP Expression Levels Predicts Recovery from Hepatitis B Virus Infection , 2012, Journal of Virology.

[22]  A. Porgador,et al.  Proliferating Cell Nuclear Antigen Is a Novel Inhibitory Ligand for the Natural Cytotoxicity Receptor NKp44 , 2011, The Journal of Immunology.

[23]  T. Beddoe,et al.  Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B , 2011, Nature.

[24]  W. Tan,et al.  Strong influence of human leukocyte antigen (HLA)‐DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population , 2011, Hepatology.

[25]  T. Hibi,et al.  Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease. , 2010, Gastroenterology.

[26]  Douglas G. Mack,et al.  Crystal structure of HLA-DP2 and implications for chronic beryllium disease , 2010, Proceedings of the National Academy of Sciences.

[27]  M. Gross,et al.  An endogenous peptide positively selects and augments the activation and survival of peripheral CD4+ T cells , 2009, Nature Immunology.

[28]  M. Gross,et al.  An endogenous peptide positively selects and augments peripheral CD4+ T cell activation and survival , 2009, Nature immunology.

[29]  Y. Kamatani,et al.  A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians , 2009, Nature Genetics.

[30]  J. Heeney,et al.  NKp44 expression, phylogenesis and function in non-human primate NK cells. , 2009, International immunology.

[31]  Huimin Zhao,et al.  Rapid identification of CD4+ T-cell epitopes using yeast displaying pathogen-derived peptide library. , 2008, Journal of immunological methods.

[32]  M. Peiris,et al.  H5-Type Influenza Virus Hemagglutinin Is Functionally Recognized by the Natural Killer-Activating Receptor NKp44 , 2007, Journal of Virology.

[33]  T. Beißbarth,et al.  A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease. , 2007, Immunity.

[34]  B. Ksander,et al.  Tumor cells transduced with the MHC class II Transactivator and CD80 activate tumor-specific CD4+ T cells whether or not they are silenced for invariant chain. , 2006, Cancer research.

[35]  Jessica M Malenfant,et al.  CD107a as a functional marker for the identification of natural killer cell activity. , 2004, Journal of immunological methods.

[36]  A. Langerak,et al.  Regulation of MHC class II expression in human T-cell malignancies. , 2004, Blood.

[37]  Akiko Kikuchi-Maki,et al.  NKp44 Triggers NK Cell Activation through DAP12 Association That Is Not Influenced by a Putative Cytoplasmic Inhibitory Sequence 1 , 2004, The Journal of Immunology.

[38]  R. Bontrop,et al.  Allelic diversity at the Mhc-DP locus in rhesus macaques (Macaca mulatta) , 2004, Immunogenetics.

[39]  S. Beck,et al.  The human TREM gene cluster at 6p21.1 encodes both activating and inhibitory single IgV domain receptors and includes NKp44 , 2003, European journal of immunology.

[40]  J. Trowsdale,et al.  Genetic Control of MHC Class II Expression , 2002, Cell.

[41]  P. Roche,et al.  Trafficking of MHC class II molecules in the late secretory pathway. , 2002, Current Opinion in Immunology.

[42]  Peter Parham,et al.  KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. , 2002, Annual review of immunology.

[43]  Angel Porgador,et al.  Recognition of viral hemagglutinins by NKp44 but not by NKp30 , 2001, European journal of immunology.

[44]  R. Biassoni,et al.  NKp44, A Triggering Receptor Involved in Tumor Cell Lysis by Activated Human Natural Killer Cells, Is a Novel Member of the Immunoglobulin Superfamily , 1999, The Journal of experimental medicine.

[45]  L. Moretta,et al.  NKp44, a Novel Triggering Surface Molecule Specifically Expressed by Activated Natural Killer Cells, Is Involved in Non–Major Histocompatibility Complex–restricted Tumor Cell Lysis , 1998, The Journal of experimental medicine.

[46]  Eric O Long,et al.  The Direct Binding of a p58 Killer Cell Inhibitory Receptor to Human Histocompatibility Leukocyte Antigen (HLA)-Cw4 Exhibits Peptide Selectivity , 1997, The Journal of experimental medicine.

[47]  M. Chang,et al.  Mechanisms by which HLA‐class II molecules protect human B lymphoid tumour cells against NK‐ and LAK‐mediated cytolysis , 1996, Immunology.

[48]  A. Barrett,et al.  Interaction of natural killer cells with MHC class II: reversal of HLA‐DR1‐mediated protection of K562 transfectant from natural killer cell‐mediated cytolysis by brefeldin‐A , 1996, Immunology.

[49]  P. Loiseau,et al.  Gene polymorphism of HLA-DPB1 and DPA1 loci in caucasoid population: frequencies and DPB1-DPA1 associations. , 1991, Human immunology.

[50]  S. Roman-Roman,et al.  LAG-3, a novel lymphocyte activation gene closely related to CD4 , 1990, The Journal of experimental medicine.

[51]  E. Nevo,et al.  Major histocompatibility complex gene organization in the mole rat Spalax ehrenbergi: evidence for transfer of function between class II genes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.